Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows used in operating activities:
Net loss for the year	$ (9,819)	$ (19,678)
Adjustments:
Amortization of intangible assets	0	781
Depreciation of equipment	0	143
Impairment of intangible assets	0	3,706
Impairment of Equipment	0	1,584
Impairment of other assets and prepaids	249	413
Stock-based compensation expense	1,337	1,174
Change in fair value of warrant liabilities	(5,197)	2,426
Write off-of deferred financing costs of at-the-market (ATM) program	0	264
Income tax recovery	(648)	0
Unrealized foreign exchange loss	(370)	814
Changes in non-cash working capital items	(2,786)	(5,946)
Net cash used in operating activities	(17,234)	(14,319)
Cash flows from (used in) investing activities:
Acquisition of equipment	0	(69)
Acquisition of short-term investments	(34,929)	(9,810)
Maturity of short-term investments	31,407	21
Net cash used in investing activities	(3,522)	(9,858)
Cash flows from (used in) financing activities:
Net proceeds from shares issued under the at-the-market (ATM) program	0	59,332
Deferred financing costs	0	(143)
Proceeds from exercise of warrants	0	183
Proceeds from exercise of stock options	0	118
Net cash from financing activities	0	59,490
Effect of exchange rate fluctuations on cash and cash equivalents	26	6,329
Translation effect on cash and cash equivalents related to reporting currency	127	(4,940)
Net (decrease) increase in cash and cash equivalents	(20,603)	36,702
Cash and cash equivalents, beginning of year	50,942	14,240
Cash and cash equivalents, end of year	30,339	50,942
Cash and cash equivalents are comprised of:
Cash	30,339	38,406
Cash equivalents	$ 0	$ 12,536